Evidence map›Paper›PMID 35835775›Full record

ArticleNPJ biofilms and microbiomes2022

In silico identification of two peptides with antibacterial activity against multidrug-resistant Staphylococcus aureus.

Linda B Oyama, Hamza Olleik, Ana Carolina Nery Teixeira, Matheus M Guidini, James A Pickup, Brandon Yeo Pei Hui, Nicolas Vidal, Alan R Cookson, Hannah Vallin, Toby Wilkinson and 12 more

Open access · goldAbstract read
In one paragraph

Article in NPJ biofilms and microbiomes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 11 institutions in 5 countries.

Linda B Oyama *Institute for Global Food Security, School of Biological Sciences, Queen's University Belfast, 19 Chlorine Gardens, Belfast, Northern Ireland, BT9 5DL, UK. l.oyama@qub.ac.uk.ORCID 0000-0002-9553-8588
Hamza Olleik *CNRS Enzyme and Cell Engineering Laboratory, Université de Technologie de Compiègne, Sorbonne Universités, Rue du Docteur Schweitzer, CS 60319, CEDEX, 60203, Compiègne, France.
Ana Carolina Nery TeixeiraDepartamento de Microbiologia, Universidade Federal de Viçosa, Viçosa, 36570-900, Brasil.
Matheus M GuidiniDepartamento de Microbiologia, Universidade Federal de Viçosa, Viçosa, 36570-900, Brasil.
James A PickupInstitute for Global Food Security, School of Biological Sciences, Queen's University Belfast, 19 Chlorine Gardens, Belfast, Northern Ireland, BT9 5DL, UK.
Brandon Yeo Pei HuiUniversity College Fairview (UCF), 4178, Jalan 1/27D, Section 6, Wangsa Maju, 53300, Kuala Lumpur, Malaysia.
Nicolas VidalYelen Analytics, Aix-Marseille University ICR, 13013, Marseille, France.
Alan R CooksonInstitute of Biological Environmental and Rural Sciences, Aberystwyth University, Aberystwyth, Wales, SY23 3DA, UK.
Hannah VallinInstitute of Biological Environmental and Rural Sciences, Aberystwyth University, Aberystwyth, Wales, SY23 3DA, UK.
Toby WilkinsonThe Roslin Institute and R(D)SVS, University of Edinburgh, Edinburgh, United Kingdom.
Denise M S BazzolliDepartamento de Microbiologia, Universidade Federal de Viçosa, Viçosa, 36570-900, Brasil.
Jennifer RichardsSpecialist Antimicrobial Chemotherapy Unit, Public Health Wales, University Hospital of Wales, Heath Park, Cardiff, CF14 4XW, UK.
Mandy WoottonSpecialist Antimicrobial Chemotherapy Unit, Public Health Wales, University Hospital of Wales, Heath Park, Cardiff, CF14 4XW, UK.
Ralf MikutKarlsruhe Institute of Technology, Institute for Automation and Applied Informatics, Hermann-von-Helmholtz-Platz 1, 76344, Eggenstein, Leopoldshafen, Germany.ORCID 0000-0001-9100-5496
Kai HilpertInstitute of Infection and Immunity, St George's, University of London, Cranmer Terrace, London, SW17 0RE, UK.ORCID 0000-0001-7131-0370
Marc MarescaAix Marseille University, CNRS, Centrale Marseille, iSm2, Marseille, France.ORCID 0000-0002-3585-4765
Josette PerrierAix Marseille University, CNRS, Centrale Marseille, iSm2, Marseille, France.
Matthias HessUC Davis, College of Agricultural and Environmental Sciences, California, 95616, CA, USA.ORCID 0000-0003-0321-0380
Hilario C MantovaniDepartamento de Microbiologia, Universidade Federal de Viçosa, Viçosa, 36570-900, Brasil.
Narcis Fernandez-FuentesInstitute of Biological Environmental and Rural Sciences, Aberystwyth University, Aberystwyth, Wales, SY23 3DA, UK.ORCID 0000-0002-6421-1080
Christopher J CreeveyInstitute for Global Food Security, School of Biological Sciences, Queen's University Belfast, 19 Chlorine Gardens, Belfast, Northern Ireland, BT9 5DL, UK.
Sharon A HuwsInstitute for Global Food Security, School of Biological Sciences, Queen's University Belfast, 19 Chlorine Gardens, Belfast, Northern Ireland, BT9 5DL, UK. s.huws@qub.ac.uk.
Queen's University Belfast · GBUniversidade Federal de Viçosa · BRAberystwyth University · GBCentre National de la Recherche Scientifique · FRUniversity Hospital of Wales · GBAix-Marseille Université · FRKarlsruhe Institute of Technology · DERoslin Institute · GBSt George's, University of London · GBUniversité de Technologie de Compiègne · FRUniversity of California, Davis · US

Funding

Biotechnology and Biological Sciences Research Council BB/L026716/1
6 · The paper itself

Abstract

Here we report two antimicrobial peptides (AMPs), HG2 and HG4 identified from a rumen microbiome metagenomic dataset, with activity against multidrug-resistant (MDR) bacteria, especially methicillin-resistant Staphylococcus aureus (MRSA) strains, a major hospital and community-acquired pathogen. We employed the classifier model design to analyse, visualise, and interpret AMP activities. This approach allowed in silico discrimination of promising lead AMP candidates for experimental evaluation. The lead AMPs, HG2 and HG4, are fast-acting and show anti-biofilm and anti-inflammatory activities in vitro and demonstrated little toxicity to human primary cell lines. The peptides were effective in vivo within a Galleria mellonella model of MRSA USA300 infection. In terms of mechanism of action, HG2 and HG4 appear to interact with the cytoplasmic membrane of target cells and may inhibit other cellular processes, whilst preferentially binding to bacterial lipids over human cell lipids. Therefore, these AMPs may offer additional therapeutic templates for MDR bacterial infections.

Indexed as

Methicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsAnimalsAnti-Bacterial AgentsAntimicrobial Cationic PeptidesHumansLipidsMicrobial Sensitivity TestsStaphylococcus aureusAnti-Bacterial AgentsAntimicrobial Cationic PeptidesLipids

Identifiers

PMID35835775
PMCPMC9283466
OpenAlexW4285495463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.